Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2004
04/29/2004US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents
04/29/2004US20040082638 Compounds, compositions and methods
04/29/2004US20040082636 Method for the prophylaxis or treatment of glomerulonephritis
04/29/2004US20040082635 Fused cyclic compounds and medicinal use thereof
04/29/2004US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
04/29/2004US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor
04/29/2004US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases
04/29/2004US20040082607 Fused heterocyclic compounds
04/29/2004US20040082592 Metabotropic glutamate receptor antagonists
04/29/2004US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders
04/29/2004US20040082586 Insecticides, nematocides
04/29/2004US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders
04/29/2004US20040082583 Chemical compounds
04/29/2004US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor
04/29/2004US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/29/2004US20040082575 Compounds and methods for modulation of estrogen receptors
04/29/2004US20040082572 Benzodiazepine derivatives as app modulators
04/29/2004US20040082562 Novel inhibitors of IMPDH enzyme
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin
04/29/2004US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease
04/29/2004CA2501706A1 Heterocyclic amides and the use thereof in the treatment of thromboembolic diseases and tumors
04/29/2004CA2501418A1 Novel compounds
04/29/2004CA2500320A1 Novel compounds with antibacterial activity
04/29/2004CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/29/2004CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/28/2004EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
04/28/2004EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists
04/28/2004EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
04/28/2004EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines
04/28/2004EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists
04/28/2004EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists
04/28/2004EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors
04/28/2004EP1411942A1 Substituted anilinic piperidines as mch selective antagonists
04/28/2004EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
04/28/2004EP1411932A1 Substituted oxazolidinones for combinational therapy
04/28/2004EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/28/2004EP1234819B1 Processes for production of oxadiazoline derivatives
04/28/2004CN1492866A Bis-triazinylaminobenzoxazole derivatives
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/28/2004CN1491949A Pyridazine-3-one derivatives, their use, and intermediate preparing them
04/28/2004CN1491945A Process for preparing human immunodeficiency virus (HIV) proteinase inhibitor
04/28/2004CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite
04/28/2004CN1147478C Pyridazine derivative and its preparation and composite containing the derivative
04/27/2004US6727364 Antiinflammatory agents
04/27/2004US6727275 Pyrrolidinone derivatives
04/27/2004US6727273 Therapy for osteoporosis, anticancer agents
04/27/2004US6727271 Oxazole or thiazole derivatives; antilipemic agents, hypotensives, antineoplastic agents
04/27/2004US6727266 Substituted tryptophan derivatives
04/27/2004US6727264 Substituted anilinic piperidines as MCH selective antagonists
04/27/2004US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents
04/27/2004US6727255 Brain, nervous system and psychological disorders
04/27/2004US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
04/27/2004US6727248 Substituted quinolinecarboxamides as antiviral agents
04/27/2004US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders
04/27/2004US6727244 Mammalian metabolites of a tachykinin receptor antagonist
04/27/2004US6727206 Substituted aryl ketones
04/27/2004US6727041 Optical recording media
04/27/2004CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds
04/22/2004WO2004033652A2 Inhibitors of fatty acid amide hydrolase
04/22/2004WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives
04/22/2004WO2004033450A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
04/22/2004WO2004033449A1 Antimicrobial 1-aryl dihydropyridone compounds
04/22/2004WO2004033437A1 Dibenzoxazepine
04/22/2004WO2004033435A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/22/2004WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders
04/22/2004WO2004033428A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
04/22/2004WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
04/22/2004WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004WO2004032882A2 Chemical compounds
04/22/2004WO2004032875A2 Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
04/22/2004WO2004032856A2 Compounds
04/22/2004WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases
04/22/2004WO2004032845A2 R-nsaid esters and their use
04/22/2004WO2004032834A2 Thrombin inhibitors
04/22/2004WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
04/22/2004WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
04/22/2004WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
04/22/2004WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
04/22/2004WO2003005999A8 Methods of treating cytokine mediated diseases
04/22/2004WO2002074752A8 Metalloproteinase inhibitors
04/22/2004US20040077880 Sulfonylpyrroles
04/22/2004US20040077878 Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
04/22/2004US20040077877 Jun n-terminal kinase inhibitors
04/22/2004US20040077871 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
04/22/2004US20040077854 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders
04/22/2004US20040077851 Receptor selective cannabimimetic aminoalkylindoles
04/22/2004US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3
04/22/2004US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
04/22/2004US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease
04/22/2004US20040077699 Substituted triazole diamine derivatives as kinase inhibitors
04/22/2004US20040077689 Abc expression promoters
04/22/2004US20040077671 Sorbitol dehydrogenase inhibitors
04/22/2004US20040077668 Compounds, compositins, and methods
04/22/2004US20040077667 Quinazolinone derivatives
04/22/2004US20040077656 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
04/22/2004US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
04/22/2004US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
04/22/2004US20040077641 Insecticides for crops
04/22/2004US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus